Aster Capital Management’s Gilead Sciences GILD Stock Holding History

Aster Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,576	Closed	-$849K	–	1002
2026 Q1	$849K	Buy	7,576 +7,253	+2,246%	+$1.02M	0.28%	88
2025 Q4	$39.6K	Sell	323 -1,363	-81%	-$166K	0.02%	513
2025 Q3	$187K	Sell	1,686 -623	-27%	-$70.8K	0.09%	265
2025 Q2	$256K	Sell	2,309 -13,302	-85%	-$1.42M	0.06%	328
2025 Q1	$1.78M	Buy	+15,611	New	+$1.61M	0.33%	67
2024 Q4	–	Sell	-10,646	Closed	-$893K	–	1260
2024 Q3	$893K	Buy	+10,646	New	+$812K	0.19%	133

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aster Capital Management's GILD Position: Q2 2026 in Review

Aster Capital Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 7,576 shares — an estimated $849K sold.

Aster Capital Management first reported a position in GILD in Q3 2024 and held it in 6 quarters. The position peaked at $1.78M in Q1 2025. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Aster Capital Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Aster Capital Management sold 7,576 Gilead Sciences shares in Q2 2026, an estimated $849K.
Aster Capital Management first reported a position in Gilead Sciences in Q3 2024 and held it in 6 quarters.
Aster Capital Management's Gilead Sciences position peaked at $1.78M in Q1 2025.
2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.